|
Volumn 60, Issue 12, 2001, Pages 1159-1160
|
Treatment of ankylosing spondylitis with infliximab [7]
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
C REACTIVE PROTEIN;
ETANERCEPT;
GADOLINIUM;
HLA B27 ANTIGEN;
IMMUNOGLOBULIN G1;
INFLIXIMAB;
MESSENGER RNA;
TUMOR NECROSIS FACTOR ALPHA;
ADULT;
ANKYLOSING SPONDYLITIS;
CASE REPORT;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
IMMUNOTHERAPY;
LETTER;
MALE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PAIN ASSESSMENT;
PRIORITY JOURNAL;
SIDE EFFECT;
ADULT;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
SPONDYLITIS, ANKYLOSING;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0035178652
PISSN: 00034967
EISSN: None
Source Type: Journal
DOI: 10.1136/ard.60.12.1159 Document Type: Letter |
Times cited : (10)
|
References (9)
|